Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-01-19 1:24 pm Purchase | 2021-01-07 | 13D | DermTech, Inc. DMTKQ | RTW INVESTMENTS LP | 3,118,666 13.090% | 460,039 (+17.30%) | Filing History |
| 2021-01-08 3:30 pm Purchase | 2020-12-10 | 13D | Rocket Pharmaceuticals, Inc. RCKT | RTW INVESTMENTS LP | 17,530,044 29.300% | 247,720 (+1.43%) | Filing History |
| 2020-12-03 09:29 am Purchase | 2020-11-06 | 13G | Cogent Biosciences, Inc. COGT | RTW INVESTMENTS LP | 1,258,750 9.990% | 1,258,750 (New Position) | Filing History |
| 2020-11-16 11:02 am Purchase | 2020-11-05 | 13G | Aptevo Therapeutics Inc. APVO | RTW INVESTMENTS LP | 178 8.970% | 178 (New Position) | Filing History |
| 2020-11-13 09:57 am Purchase | 2020-11-03 | 13G | Fulcrum Therapeutics, Inc. FULC | RTW INVESTMENTS LP | 2,071,409 7.550% | 2,071,409 (New Position) | Filing History |
| 2020-10-26 2:16 pm Purchase | 2020-10-16 | 13G | Tarsus Pharmaceuticals, Inc. TARS | RTW INVESTMENTS LP | 2,463,601 12.790% | 2,463,601 (New Position) | Filing History |
| 2020-09-28 3:59 pm Purchase | 2020-09-18 | 13G | Athira Pharma, Inc. ATHA | RTW INVESTMENTS LP | 2,668,913 8.660% | 2,668,913 (New Position) | Filing History |
| 2020-06-29 2:51 pm Purchase | 2020-06-19 | 13G | IVERIC bio, Inc. ISEE | RTW INVESTMENTS LP | 6,121,882 8.070% | 6,121,882 (New Position) | Filing History |
| 2020-06-22 09:14 am Purchase | 2020-06-11 | 13D | Avidity Biosciences, Inc. RNA | RTW INVESTMENTS LP | 3,995,000 11.300% | 3,995,000 (New Position) | Filing History |
| 2020-06-19 10:36 am Purchase | 2020-06-11 | 13G | Celldex Therapeutics, Inc. CLDX | RTW INVESTMENTS LP | 1,885,000 9.950% | 1,885,000 (New Position) | Filing History |
| 2020-06-11 08:54 am Purchase | 2020-06-01 | 13G | Relmada Therapeutics, Inc. RLMD | RTW INVESTMENTS LP | 1,255,857 8.260% | 1,255,857 (New Position) | Filing History |
| 2020-05-22 12:37 pm Purchase | 2020-05-15 | 13G | Oyster Point Pharma, Inc. OYST | RTW INVESTMENTS LP | 1,914,606 7.620% | 1,914,606 (New Position) | Filing History |